Filing Details
- Accession Number:
- 0001415889-24-023625
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-09-18 16:32:59
- Reporting Period:
- 2024-09-16
- Accepted Time:
- 2024-09-18 16:32:59
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1428336 | Healthequity Inc. | HQY | Services-Business Services, Nec (7389) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1615062 | Jon Kessler | C/O Healthequity, Inc. 15 W. Scenic Pointe Dr., Ste. 100 Draper UT 84020 | President And Ceo | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2024-09-16 | 17,338 | $78.31 | 208,163 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-09-16 | 3,661 | $78.94 | 204,502 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-09-16 | 7,239 | $78.32 | 102,746 | No | 4 | S | Indirect | by GKF, LLC |
Common Stock | Disposition | 2024-09-16 | 1,511 | $78.93 | 101,235 | No | 4 | S | Indirect | by GKF, LLC |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Indirect | by GKF, LLC |
No | 4 | S | Indirect | by GKF, LLC |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | $41.28 | 2027-03-27 | 17,409 | 17,409 | Direct | |
Common Stock | Stock Option (right to buy) | $61.72 | 2028-03-27 | 23,929 | 23,929 | Direct | |
Common Stock | Stock Option (right to buy) | $73.61 | 2029-03-26 | 38,343 | 38,343 | Direct | |
Common Stock | Stock Option (right to buy) | $41.28 | 2027-03-27 | 34,820 | 34,820 | Indirect | |
Common Stock | Stock Option (right to buy) | $61.72 | 2028-03-27 | 23,930 | 23,930 | Indirect | |
Common Stock | Stock Option (right to buy) | $73.61 | 2029-03-26 | 12,782 | 12,782 | Indirect |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2027-03-27 | 17,409 | 17,409 | Direct |
2028-03-27 | 23,929 | 23,929 | Direct |
2029-03-26 | 38,343 | 38,343 | Direct |
2027-03-27 | 34,820 | 34,820 | Indirect |
2028-03-27 | 23,930 | 23,930 | Indirect |
2029-03-26 | 12,782 | 12,782 | Indirect |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 25, 2024.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.82 to $78.82, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of theSecurities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes (2,3,and 4) of this Form 4.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.825 to $79.15, inclusive.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.82 to $78.82, inclusive.
- These securities are held by the GKF, LLC. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
- The option is immediately exercisable.